Skip Navigation
Skip to contents

J Korean Med Sci.  2009 Dec;24(6):1203-1206. 10.3346/jkms.2009.24.6.1203.

Fibrinogen Yecheon: Congenital Dysfibrinogenemia with Gamma Methionine-310 to Threonine Substitution

Affiliations
  • 1Department of Internal Medicine, Hemato-oncology, Chung-Ang University Hospital, Seoul, Korea.
  • 2Department of Laboratory Medicine, Chung-Ang University Hospital, Seoul, Korea. chayoung@cau.ac.kr
  • 3Department of Laboratory Medicine, Soonchunhyang University Hospital, Seoul, Korea.
  • 4Department of Laboratory Medicine, Samsung Medical Center, Seoul, Korea.

Abstract

This case study reports a rare fibrinogen variant, gamma Met310Thr mutation, for the first time in Korea. The case shows a point mutation from T to C in the 1,007th nucleotide of the FGG gene. This report describes a variant fibrinogen, hereinafter called "fibrinogen Yecheon", using the name after the town where the patient was living at the time of diagnosis. Fibrinogen Yecheon has a de novo heterozygous point mutation of FGG resulting in gamma Met310Thr and subsequent extra N-glycosylation at gamma Asn308. Extra N-glycosylated fibrinogen is considered a main inhibitor of normal fibrinogen activity.

Keyword

Fibrinogen; Dysfibrinogenemia; FGG Mutation; Fibrinogen Yecheon

MeSH Terms

Base Sequence
*Blood Coagulation Disorders, Inherited/genetics/physiopathology
DNA Mutational Analysis
Fibrinogens, Abnormal/*genetics
Humans
Korea
Male
Methionine/*genetics
Molecular Sequence Data
*Point Mutation
Threonine/*genetics
Young Adult
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr